Cargando…

Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients

BACKGROUND & AIMS: Tumor-associated chronic inflammation has been determined to play a crucial role in tumor progression, angiogenesis and immunosuppression. The objective of this study was to assess the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte rati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Ming-Yang, Liu, Zhi-Peng, Pan, Yu, Wang, Jiao-Yang, Wang, Xiang, Dai, Hai-Su, Gao, Shu-Yang, Zhong, Shi-Yun, Che, Xiao-Yu, Zuo, Jing-Hua, Liu, Yun-Hua, Liu, Xing-Chao, Fan, Hai-Ning, Chen, Wei-Yue, Wang, Zi-Ran, Yin, Xian-Yu, Bai, Jie, Zhang, Yan-Qi, Jiang, Yan, Gong, Yi, Chen, Zhi-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845724/
https://www.ncbi.nlm.nih.gov/pubmed/36686802
http://dx.doi.org/10.3389/fonc.2022.1104810
_version_ 1784870974393417728
author Ge, Ming-Yang
Liu, Zhi-Peng
Pan, Yu
Wang, Jiao-Yang
Wang, Xiang
Dai, Hai-Su
Gao, Shu-Yang
Zhong, Shi-Yun
Che, Xiao-Yu
Zuo, Jing-Hua
Liu, Yun-Hua
Liu, Xing-Chao
Fan, Hai-Ning
Chen, Wei-Yue
Wang, Zi-Ran
Yin, Xian-Yu
Bai, Jie
Zhang, Yan-Qi
Jiang, Yan
Gong, Yi
Chen, Zhi-Yu
author_facet Ge, Ming-Yang
Liu, Zhi-Peng
Pan, Yu
Wang, Jiao-Yang
Wang, Xiang
Dai, Hai-Su
Gao, Shu-Yang
Zhong, Shi-Yun
Che, Xiao-Yu
Zuo, Jing-Hua
Liu, Yun-Hua
Liu, Xing-Chao
Fan, Hai-Ning
Chen, Wei-Yue
Wang, Zi-Ran
Yin, Xian-Yu
Bai, Jie
Zhang, Yan-Qi
Jiang, Yan
Gong, Yi
Chen, Zhi-Yu
author_sort Ge, Ming-Yang
collection PubMed
description BACKGROUND & AIMS: Tumor-associated chronic inflammation has been determined to play a crucial role in tumor progression, angiogenesis and immunosuppression. The objective of this study was to assess the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in perihilar cholangiocarcinoma (pCCA) patients following curative resection. METHODS: Consecutive pCCA patients following curative resection at 3 Chinese hospitals between 2014 and 2018 were included. The NLR was defined as the ratio of neutrophil count to lymphocyte count. PLR was defined as the ratio of platelet count to lymphocyte count. The optimal cutoff values of preoperative NLR and PLR were determined according to receiver operating characteristic (ROC) curves for the prediction of 1-year overall survival (OS), and all patients were divided into high- and low-risk groups. Kaplan-Meier curves and Cox regression models were used to investigate the relationship between values of NLR and PLR and values of OS and recurrence-free survival (RFS) in pCCA patients. The usefulness of NLR and PLR in predicting OS and RFS was evaluated by time-dependent ROC curves. RESULTS: A total of 333 patients were included. According to the ROC curve for the prediction of 1-year OS, the optimal cutoff values of preoperative NLR and PLR were 1.68 and 113.1, respectively, and all patients were divided into high- and low-risk groups. The 5-year survival rates in the low-NLR (<1.68) and low-PLR groups (<113.1) were 30.1% and 29.4%, respectively, which were significantly higher than the rates of 14.9% and 3.3% in the high-NLR group (≥1.68) and high-PLR group (≥113.1), respectively. In multivariate analysis, high NLR and high PLR were independently associated with poor OS and RFS for pCCA patients. The time-dependent ROC curve revealed that both NLR and PLR were ideally useful in predicting OS and RFS for pCCA patients. CONCLUSIONS: This study found that both NLR and PLR could be used to effectively predict long-term survival in patients with pCCA who underwent curative resection.
format Online
Article
Text
id pubmed-9845724
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98457242023-01-19 Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients Ge, Ming-Yang Liu, Zhi-Peng Pan, Yu Wang, Jiao-Yang Wang, Xiang Dai, Hai-Su Gao, Shu-Yang Zhong, Shi-Yun Che, Xiao-Yu Zuo, Jing-Hua Liu, Yun-Hua Liu, Xing-Chao Fan, Hai-Ning Chen, Wei-Yue Wang, Zi-Ran Yin, Xian-Yu Bai, Jie Zhang, Yan-Qi Jiang, Yan Gong, Yi Chen, Zhi-Yu Front Oncol Oncology BACKGROUND & AIMS: Tumor-associated chronic inflammation has been determined to play a crucial role in tumor progression, angiogenesis and immunosuppression. The objective of this study was to assess the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in perihilar cholangiocarcinoma (pCCA) patients following curative resection. METHODS: Consecutive pCCA patients following curative resection at 3 Chinese hospitals between 2014 and 2018 were included. The NLR was defined as the ratio of neutrophil count to lymphocyte count. PLR was defined as the ratio of platelet count to lymphocyte count. The optimal cutoff values of preoperative NLR and PLR were determined according to receiver operating characteristic (ROC) curves for the prediction of 1-year overall survival (OS), and all patients were divided into high- and low-risk groups. Kaplan-Meier curves and Cox regression models were used to investigate the relationship between values of NLR and PLR and values of OS and recurrence-free survival (RFS) in pCCA patients. The usefulness of NLR and PLR in predicting OS and RFS was evaluated by time-dependent ROC curves. RESULTS: A total of 333 patients were included. According to the ROC curve for the prediction of 1-year OS, the optimal cutoff values of preoperative NLR and PLR were 1.68 and 113.1, respectively, and all patients were divided into high- and low-risk groups. The 5-year survival rates in the low-NLR (<1.68) and low-PLR groups (<113.1) were 30.1% and 29.4%, respectively, which were significantly higher than the rates of 14.9% and 3.3% in the high-NLR group (≥1.68) and high-PLR group (≥113.1), respectively. In multivariate analysis, high NLR and high PLR were independently associated with poor OS and RFS for pCCA patients. The time-dependent ROC curve revealed that both NLR and PLR were ideally useful in predicting OS and RFS for pCCA patients. CONCLUSIONS: This study found that both NLR and PLR could be used to effectively predict long-term survival in patients with pCCA who underwent curative resection. Frontiers Media S.A. 2023-01-04 /pmc/articles/PMC9845724/ /pubmed/36686802 http://dx.doi.org/10.3389/fonc.2022.1104810 Text en Copyright © 2023 Ge, Liu, Pan, Wang, Wang, Dai, Gao, Zhong, Che, Zuo, Liu, Liu, Fan, Chen, Wang, Yin, Bai, Zhang, Jiang, Gong and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ge, Ming-Yang
Liu, Zhi-Peng
Pan, Yu
Wang, Jiao-Yang
Wang, Xiang
Dai, Hai-Su
Gao, Shu-Yang
Zhong, Shi-Yun
Che, Xiao-Yu
Zuo, Jing-Hua
Liu, Yun-Hua
Liu, Xing-Chao
Fan, Hai-Ning
Chen, Wei-Yue
Wang, Zi-Ran
Yin, Xian-Yu
Bai, Jie
Zhang, Yan-Qi
Jiang, Yan
Gong, Yi
Chen, Zhi-Yu
Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
title Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
title_full Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
title_fullStr Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
title_full_unstemmed Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
title_short Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
title_sort assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: a multicenter study of 333 patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845724/
https://www.ncbi.nlm.nih.gov/pubmed/36686802
http://dx.doi.org/10.3389/fonc.2022.1104810
work_keys_str_mv AT gemingyang assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT liuzhipeng assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT panyu assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT wangjiaoyang assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT wangxiang assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT daihaisu assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT gaoshuyang assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT zhongshiyun assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT chexiaoyu assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT zuojinghua assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT liuyunhua assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT liuxingchao assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT fanhaining assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT chenweiyue assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT wangziran assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT yinxianyu assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT baijie assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT zhangyanqi assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT jiangyan assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT gongyi assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients
AT chenzhiyu assessmentoftheprognosticvalueoftheneutrophiltolymphocyteratioandplatelettolymphocyteratioinperihilarcholangiocarcinomapatientsfollowingcurativeresectionamulticenterstudyof333patients